Insights

Minaris Regenerative Medicine’s leaders and experts are proud to share their knowledge and insight with the cell and gene therapy industry. Please review our current and past blog posts on topics of interest to this emerging industry.

*This page may include mention of our past company names as it reflects content distributed in the past. The former companies Hitachi Chemical Advanced Therapeutics Solutions (HCATS, formerly PCT or PCT Cell Therapy Services), apceth Biopharma GmBH are all now operations under the name Minaris Regenerative Medicine. Hitachi Chemical Co., Ltd. has been renamed Showa Denko Materials Co., Ltd.

April 27, 2016

Patient-Specific Cell Therapies: Not your Grandfather’s Therapies

The following is an excerpt from an article published in the April issue of BioProcess international, entitled “Factories of the Future: Can Patient-Specific Cell ...

February 12, 2016

The Passion for and Potential of T Cells: Expert Insights

1. Why are T cells promising/exciting in cell therapy right now? What potential do you see? “T cells play a central role in the immune response, as they have the ...

December 9, 2015

NK Cells--Why Not?

The following post was originally published in the November 2015 edition of The Vector, the online newsletter for the American Society of Gene and Cell Therapy. Chimeric ...

October 12, 2015

Challenges and Opportunities in CAR-T Therapy

The upcoming CAR-T Summit in Boston (November 12-13) is an opportunity for leaders from pharma, biotech and academia to get together to discuss “clinical strategy, ...

September 9, 2015

The Evolution of the Commercial Manufacturing Facility for Cell Therapy

The following is an excerpt of a commentary originally published in the September issue of DDNews, entitled, “Building a Problem or a Solution? : Removing the ...

August 4, 2015

Bridging the Gap with Chimeric Antigen Receptors

Cell therapies armed with crafted weaponry in the form of CARs (Chimeric antigen receptors) and engineered TCRs (T cell receptors) have taken immuno-oncology to a new ...

July 14, 2015

Understanding Technology Transfer, a Critical Aspect of Cell Therapy Manufacturing

Below is an excerpt on technology transfer in cell therapy manufacturing originally published in the April 2015 issue of BioProcess International as part of the article, ...

January 23, 2012

Bench To Bedside: Cell Therapy Development and Commercialization Roadmap

PCT's Dr. Sanjin Zvonic, drawing on more than 12 years of PCT's philosophy, experience and expertise, gives an overview of the key steps in the commercialization of cell ...

Previous All Posts